The impact of PI3K/AKT inhibitor on the radiosensitization of breast cancer cells

被引：0
|
作者：
Fu, S
Zeng, QW
Sun, Y
Zhang, Q
Shao, YH
Jian, GL
机构：
[1] Jiao Tong Univ, Shanghai Hosp 6, Shanghai 200233, Peoples R China
[2] Fudan Univ, Shanghai Canc Hosp, Shanghai 200032, Peoples R China
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 78卷
关键词：
breast cancer; Ly294002; PI3K; AKT; radiotherapy;
D O I：
10.1016/S0167-8140(06)80740-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
263
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    [J]. Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [2] Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
    Bortul, R
    Tazzari, PL
    Billi, AM
    Tabellini, G
    Mantovani, I
    Cappellini, A
    Grafone, T
    Martinelli, G
    Conte, R
    Martelli, AM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 677 - 686
  • [3] First PI3K Inhibitor for Breast Cancer
    Voelker, Rebecca
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (01): : 19 - 19
  • [4] PI3K/Akt/mTOR inhibitors in breast cancer
    Lee, Joycelyn J. X.
    Loh, Kiley
    Yap, Yoon-Sim
    [J]. CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 342 - 354
  • [5] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    [J]. Cancer Biology & Medicine, 2015, (04) : 342 - 354
  • [6] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    [J]. Cancer Biology & Medicine., 2015, 12 (04) - 354
  • [7] AQP3-Dependent PI3K/Akt Modulation in Breast Cancer Cells
    Mlinaric, Monika
    Lucic, Ivan
    Milkovic, Lidija
    da Silva, Ines V.
    Tartaro Bujak, Ivana
    Musani, Vesna
    Soveral, Graca
    Gasparovic, Ana Cipak
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [8] PI3K/Akt and Stem Cells in two breast cancer cell lines.
    Cerliani, Juan
    Gargini, Ricardo
    Calvo, Juan
    Lanari, Claudia
    Izquierdo, Marta
    [J]. CANCER RESEARCH, 2008, 68 (09)
  • [9] The role of the PTEN/PI3K/AKT-survival pathway for radiosensitization
    Zingg, D
    Tenzer, A
    Hofstetter, B
    Glanzmann, C
    Bodis, S
    Pruschy, M
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 114 - 114
  • [10] Combined perifosine (PI3K/AKT inhibitor) and radiotherapy for prostate cancer
    Gao, Y.
    Wang, X.
    Zhu, J.
    Mai, W.
    Huang, Y.
    Floryk, D.
    Ittmann, M.
    Butler, E. B.
    Teh, B. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S712 - S713
12345